Capital Management Associates (New York)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,400
| Closed | -$790K | – | 84 |
|
|
2023
Q3 | $790K | Hold |
11,400
| – | – | 1.16% | 31 |
|
|
2023
Q2 | $1.08M | Hold |
11,400
| – | – | 1.58% | 18 |
|
|
2023
Q1 | $943K | Hold |
11,400
| – | – | 1.43% | 29 |
|
|
2022
Q4 | $851K | Hold |
11,400
| – | – | 1.26% | 36 |
|
|
2022
Q3 | $942K | Hold |
11,400
| – | – | 1.37% | 29 |
|
|
2022
Q2 | $1.08M | Hold |
11,400
| – | – | 1.6% | 23 |
|
|
2022
Q1 | $1.34M | Hold |
11,400
| – | – | 1.44% | 25 |
|
|
2021
Q4 | $1.48M | Hold |
11,400
| – | – | 1.45% | 20 |
|
|
2021
Q3 | $1.29M | Hold |
11,400
| – | – | 1.27% | 33 |
|
|
2021
Q2 | $1.18M | Hold |
11,400
| – | – | 1.13% | 40 |
|
|
2021
Q1 | $953K | Hold |
11,400
| – | – | 0.98% | 47 |
|
|
2020
Q4 | $1.04M | Hold |
11,400
| – | – | 1.14% | 39 |
|
|
2020
Q3 | $910K | Hold |
11,400
| – | – | 1.2% | 34 |
|
|
2020
Q2 | $788K | Hold |
11,400
| – | – | 1.11% | 38 |
|
|
2020
Q1 | $717K | Hold |
11,400
| – | – | 1.3% | 31 |
|
|
2019
Q4 | $887K | Hold |
11,400
| – | – | 1.22% | 31 |
|
|
2019
Q3 | $836K | Hold |
11,400
| – | – | 1.29% | 25 |
|
|
2019
Q2 | $702K | Hold |
11,400
| – | – | 1.14% | 30 |
|
|
2019
Q1 | $727K | Hold |
11,400
| – | – | 1.13% | 27 |
|
|
2018
Q4 | $582K | Hold |
11,400
| – | – | 1.1% | 35 |
|
|
2018
Q3 | $662K | Buy |
11,400
+2,835
| +33% | +$165K | 0.82% | 46 |
|
|
2018
Q2 | $416K | Buy |
+8,565
| New | +$416K | 0.52% | 94 |
|